CLINICAL TRIALS PROFILE FOR PERCODAN-DEMI
✉ Email this page to a colleague
All Clinical Trials for PERCODAN-DEMI
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00771758 ↗ | Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis | Completed | Grünenthal GmbH | Phase 3 | 2008-09-01 | The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate. |
NCT00771758 ↗ | Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis | Completed | Ortho-McNeil Janssen Scientific Affairs, LLC | Phase 3 | 2008-09-01 | The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate. |
NCT04752384 ↗ | Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients | Recruiting | Medical College of Wisconsin | Phase 2 | 2021-07-08 | This is a single-arm prospective clinical trial to determine the safety and feasibility of using transdermal buprenorphine in alleviation of radiation induced mucositis pain in head and neck cancer patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PERCODAN-DEMI
Condition Name
Clinical Trial Locations for PERCODAN-DEMI
Trials by Country
Clinical Trial Progress for PERCODAN-DEMI
Clinical Trial Phase
Clinical Trial Sponsors for PERCODAN-DEMI
Sponsor Name